896117-64-9
Chemical Structure
GSK931145
- CAS No.: 896117-64-9
- Formula:C23H30N2O
- Molecular Weight:350.50
IUPAC Name: N-((1-(dimethylamino)cyclopentyl)(phenyl)methyl)-2,6-dimethylbenzamide
InChIKey: BMXRRRIDMAIEKX-UHFFFAOYSA-N
SMILES: O=C(C1=C(C)C=CC=C1C)NC(C2(CCCC2)N(C)C)C3=CC=CC=C3
Biological Activity: GSK931145 is a glycine transporter 1 (GlyT1) inhibitor with anti-epileptic activity. GSK931145 exhibits a low minimum effective dose in the maximum electrical stimulation threshold test, indicating that it has a significant anti-epileptic effect. GSK931145 is also suitable as a positron emission tomography (PET) radioligand for quantifying the availability of glycine transporters in the living brain[1].
| Cat. No. | Nom du produit | Pureté | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
GSK931145 | GSK931145 is a glycine transporter 1 (GlyT1) inhibitor with anti-epileptic activity. GSK931145 exhibits a low minimum effective dose in the maximum electrical stimulation threshold test, indicating that it has a significant anti-epileptic effect. GSK931145 is also suitable as a positron emission tomography (PET) radioligand for quantifying the availability of glycine transporters in the living brain. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Keywords
